Alert: A Specialty Issue of Clinical Therapeutics Edited by Massachusetts Cannabis Control Commission Research Department is Now Available
WORCESTER— This month, Elsevier published the first of a two-part 2026 specialty issue of Clinical Therapeutics, a peer-reviewed medical journal guest edited by the Massachusetts Cannabis Control Commission (Commission) Research Department, focused on the intersection of cannabis research and regulation.
The specialty Clinical Therapeutics issue, which follows the first-ever cannabis issue published in 2023, aims to highlight recent policy changes and research gaps needed to facilitate evidence-based policy in legalized jurisdictions across the globe. The Commission, in collaboration with Elsevier, the publisher of the journal, first issued a call for papers in January 2025, and accepted submissions until September 2025. Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research.
